Each day in the United States, roughly 56,000 patients have a test that can help diagnose heart problems, cancer progression in bones and other medical conditions.
The most common version is a nuclear stress test that shows images of blood flow to the heart. Each test, or scan, uses a nuclear isotope that must be shipped from Europe, Australia or South Africa. It is not made in large quantities in the Western Hemisphere, and its supply — which comes from aging nuclear reactors — is increasingly precarious.
A Janesville company founded by a physicist who grew up in Brookfield is on track to change that.
Shine Medical Technologies began construction last spring on a plant — projected to cost more than $100 million — that could supply two-thirds of the U.S. demand for the isotope.
Read the full article here.
